VAERS 2678767
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN0173
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 01.09.2023
- Impfdatum
- 20.05.2021
- Beginn
- 10.06.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- - / RA
Symptomtext
Brain fog; headaches; memory loss; changes in mood; partial disability; aphasia; severe anxiety; depression; body aches; tinitus; can't focus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20May2021 as dose 2, single (Lot number: EN0173) at the age of 41 years, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot Number: EN0162, Location of injection: Arm Left; Administration time: 03:30 PM), administration date: 20Apr2021, when the patient was 41-year-old, for COVID-19 Immunization. The following information was reported: BRAIN FOG (disability) with onset 10Jun2021, outcome "not recovered"; APHASIA (disability) with onset 10Jun2021, outcome "not recovered"; PAIN (disability) with onset 10Jun2021, outcome "not recovered", described as "body aches"; DISTURBANCE IN ATTENTION (disability) with onset 10Jun2021, outcome "not recovered", described as "can't focus"; MOOD ALTERED (disability) with onset 10Jun2021, outcome "not recovered", described as "changes in mood"; DEPRESSION (disability) with onset 10Jun2021, outcome "not recovered"; HEADACHE (disability) with onset 10Jun2021, outcome "not recovered", described as "headaches"; AMNESIA (disability) with onset 10Jun2021, outcome "not recovered", described as "memory loss"; DISABILITY (disability) with onset 10Jun2021, outcome "not recovered", described as "partial disability"; ANXIETY (disability) with onset 10Jun2021, outcome "not recovered", described as "severe anxiety"; TINNITUS (disability) with onset 10Jun2021, outcome "not recovered", described as "tinitus". The events "brain fog", "headaches", "memory loss", "changes in mood", "partial disability", "aphasia", "severe anxiety", "depression", "body aches", "tinitus" and "can't focus" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of brain fog, headache, amnesia, mood altered, disability, aphasia, anxiety, depression, pain, tinnitus, disturbance in attention. Clinical course: Patient had severe Brain fog, headaches, memory loss, changes in mood, partial disability as a result, aphasia, and severe anxiety beginning about 2 weeks month after the 2nd dose. Over the next year the brain fog improved slightly but the other issues remained and depression and body aches were added to the symptoms. Patient is now permanently disabled and have frequent headaches, anxiety, memory loss, brain fog, aphasia, mood issues, and can't focus. She also developed tinnitus.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -